Market revenue in 2021 | USD 36.0 million |
Market revenue in 2028 | USD 121.0 million |
Growth rate | 18.9% (CAGR from 2021 to 2028) |
Largest segment | Left ventricular assist devices |
Fastest growing segment | Total Artificial Heart (TAH) |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Left ventricular assist devices, Right ventricular assist devices, Bi-ventricular assist devices, Total Artificial Heart (TAH) |
Key market players worldwide | Johnson & Johnson, Medtronic PLC, Abbott Laboratories, Cardio Diagnostics Holdings Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ventricular assist device market will help companies and investors design strategic landscapes.
Left ventricular assist devices was the largest segment with a revenue share of 82.5% in 2021. Horizon Databook has segmented the South Korea ventricular assist device market based on left ventricular assist devices, right ventricular assist devices, bi-ventricular assist devices, total artificial heart (tah) covering the revenue growth of each sub-segment from 2018 to 2028.
Rising prevalence of cardiovascular illnesses such as hypertension, ventricular septal defect, heart failure, and stroke is driving the adoption of ventricular assist devices for treating heart diseases. In addition, the scarcity of heart donors is further aiding the market growth in the country.
According to the Institution of Health Metrics and Evolution, 20.0% and 2.4% of the total population in South Korea died due to ischemic heart diseases and stoke in 2017. Moreover, consumption of alcohol and tobacco has also increased to 20.0% and 7.5%, respectively. Therefore, increase in prevalence of CVDs and government expenditure on healthcare (USD 2,150 million in 2017) is anticipated to boost market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea ventricular assist device market , including forecasts for subscribers. This country databook contains high-level insights into South Korea ventricular assist device market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account